While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist ...
Mihai Gheorghiade, M.D., of the Northwestern University Feinberg School of Medicine, Chicago, and colleagues randomly assigned 456 patients with worsening chronic HF and reduced left ventricular ...
Please provide your email address to receive an email when new articles are posted on . Addition of soluble urokinase-type plasminogen activator receptor levels to models including B-type natriuretic ...
Research published in the April 2011 issue of Anesthesiology examines whether the hormone plasma B-type natriuretic peptide helps indicate which patients are at risk of adverse cardiac events after ...
Brain natriuretic peptide (BNP), a substance secreted by the heart that is associated with congestive heart failure and renal failure, does not predict reduction in systolic blood pressure (BP) in ...
BNP levels in the blood reflects the severity of cardiac dysfunction. Higher BNP levels have been associated with adverse clinical outcomes. This study looked at end-stage heart failure patients with ...
Dr. Pankaj Arora, MD, FAHA, is a physician scientist in the Division of Cardiovascular Disease with expertise in the human genetics and genomics of complex cardiovascular traits, as well as ...
Using Mendelian randomization, Roman Pfister of the University of Cambridge, UK and colleagues demonstrate a potentially causal link between low levels of B-type natriuretic peptide (BNP), a hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results